We investigated the effects of plasma from dogs with perinephritk hypertension on the Na+-K+pump of cultured dog vascular smooth muscle cells. We also measured [3H]ouabaln binding by myocardium and vascular tissue. Fresh, unprocessed plasma from healthy dogs during the first 6 weeks of benign one-kidney, one wrapped hypertension and from paired normotensive control dogs was layered over confluent primary cultured puppy aortic smooth muscle cells that had been sodium-loaded with monensin. In 26 paired assays of plasina from four pairs of dogs, cells incubated in the presence of plasma from hypertensive dogs had significantly reduced total (p< 0.01) and ouabain-sensitive (p< 0.001)86Rb+uptakes, but their intracellular sodium content did not differ from cells incubated in paired normotensive plasma. We no longer detected these uptake differences when passaged cells or cells cocultured with bovine endotheliaJ cells were used for assay or when plasma was treated with protease inhibitors or boiled. However, boiled plasma increased the sodium content of the assay cells, suggesting an ionophorelike effect. Levels of pump inhibitory activity in plasma appeared to remain constant during Weeks 1 to 6 of hypertension. We found no evidence for altered numbers of pump sites in cardiovascular tissues from these hypertensive dogs.'These findings support the hypothesis that plasma factors inhibit the membrane Na+-K+pump in vascular smooth muscle cells in this form of hypertension. These plasma inhibitory factors apparently do not induce pump molecules.